1.Zheng B, Chen Y, Niu L, et al. Modulating the tumoral SPARC content to enhance albumin-based drug delivery for cancer therapy.Journal of Controlled Release. 2024;366:596-610.
2.Wang J#, Yang Y#, Zhang X, Li Z, Chen Y,Zheng B*, Cai Z*. Targeting ERCC2 with siRNA self-assembled nanoparticles to enhance the cisplatin response in bladder cancer.ACS Applied Nano Materials. 2024;7(21):24388–24400.
3.Zheng B#, Niu L#, Xu H, et al. Engineering redirected NF-κB/OIP5 expression programs to enhance tumor responses to chemotherapy in bladder cancer.Science Bulletin. 2023;68(24):3207-3224.
4.Hu Z#,Zheng B#, Xu J#, et al. An albumin-bound drug conjugate of paclitaxel and the indoleamine-2,3-dioxygenase inhibitor for enhanced cancer chemo-immunotherapy.Nanotechnology. 2020;31:295101.
5.Zheng B, Xu J, Chen G, et al. Bacterium-mimicking vector with enhanced adjuvanticity for cancer immunotherapy and minimized toxicity.Advanced Functional Materials. 2019;29:1901437.